HTA Collections

NameStartedScope Ascending orderActions
Abdominal Aorta Aneurysm Screening 4.5.2011 AAA Screening compared to not doing anything in the screening of Abdominal Aorta Aneurysm (AAA) in elderly at moderate risk of developing AAA View
Fecal Immunochemical Test (FIT ) versus guaiac-based fecal occult blood test (FOBT) for colorectal cancer screening 5.4.2013 Fecal Immunochemical Test (FIT) for colorectal cancer screening compared to CRC screening with Guaiac –based fecal occult blood test (gFOBT) in the screening of Adenomas, as non-malignant precursor lesions of ColoRectal Cancer (CRC). in healthy and/or asymptomatic adults and elderly Any adult over 50 years old, both men and women, with average risk of CRC. View
Use of Intravenous immunoglobulins for Alzeheimer’s disease including Mild Cognitive Impairment 13.1.2014 Immunoglobulins (IGG) compared to placebo, not doing anything or Usual supportive care in the treatment of Alzheimer’s disease in elderly AD is diagnosed mostly in people over 65 years of age, although there is an early-onset form that can occur much earlier. According to Wikipedia in 2006, there were 26.6 million sufferers worldwide. View
Structured telephone support (STS) for adult patients with chronic heart failure 9.9.2014 Structured telephone support (STS) for adult patients with chronic heart failure compared to Usual care defined as regular schedules of visits of the patient at the heart center/ GP/cardiologist or patient has to move (≠ at home) in the prevention of Chronic cardiac failure in adults and elderly with chronic heart failure (CHF) AND hospitalization due to heart failure at least once AND without implanted devices View
Prognostic tests for breast cancer recurrence (uPA/PAI-1 [FEMTELLE], MammaPrint, Oncotype DX ) 13.6.2011 UPA/PAI-1 (FEMTELLE), MammaPrint, Oncotype DX compared to Standard of care in selecting treatment for Breast cancer recurrence in females View

Rapid assessments available as PDF

  • Duodenal-jejunal bypass sleeve for the treatment of obesity with or without Type II Diabetes Mellitus, 2013
  • Renal denervation systems for treatment-resistant hypertension, 2013
  • Zostavax for the prevention herpes zoster, 2013
  • Canagliflozin for the treatment of type 2 diabetes mellitus, 2014
  • Balloon Eustachian Tuboplasty for the treatment of Eustachian tube dysfunction, 2015
  • Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenosis, 2015
  • Ramucirumab (Cyramza®) in combination with Paclitaxel as second-line treatment for adult patients with advanced gastric or gastro-oesophageal junction adenocarcinoma, 2015
  • Sorafenib (Nexavar®) and its use for the treatment of progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma refractory to radioactive iodine, 2015
  • Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation, 2015
  • Vorapaxar (ZONTIVITY™) for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infection (MI), 2015
  • Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke, 2015
  • New pharmaceuticals for the treatment of chronic Hepatitis C, 2015